Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
High mobility group box 1 pseudogene 6 (HMGB1P6) is a processed human pseudogene located in the HMGB1 gene family. Unlike the protein-coding HMGB1, which has broad regulatory and inflammatory roles, HMGB1P6 does not encode functional protein and is instead thought to exert regulatory effects by acting as a competitive endogenous RNA (ceRNA). This ceRNA activity allows HMGB1P6 to bind miRNAs that would otherwise inhibit HMGB1, thereby potentially modulating HMGB1 levels and influencing cellular stress responses, gene regulation, and carcinogenesis indirectly. Upregulation of HMGB1P6 is noted in specific cancer contexts, including endometrial, uterine, and ovarian cancers, although its primary role is non-protein coding and regulatory at the RNA level.
Not applicable; mechanisms described in literature center on RNA interference, miRNA sponging, or ceRNA effects, not drug interaction
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on High mobility group box 1 pseudogene 6 (HMGB1P6).